2,851
edits
Bioavailability: Difference between revisions
→Relative Bioavailability:
| Line 25: | Line 25: | ||
where AUC is the [[Area Under the Curve (AUC)|area under the plasma concentration-time curve]] for oral (AUC<sub>oral</sub>) and intravenous (AUC<sub>IV</sub>) administration, and Dose refers to the dose administered via each route. | where AUC is the [[Area Under the Curve (AUC)|area under the plasma concentration-time curve]] for oral (AUC<sub>oral</sub>) and intravenous (AUC<sub>IV</sub>) administration, and Dose refers to the dose administered via each route. | ||
=== '''Relative Bioavailability''' | === '''Relative Bioavailability'''=== | ||
This compares the bioavailability of a drug in different formulations, usually against a standard. The formula is: | This compares the bioavailability of a drug in different formulations, usually against a standard. The formula is: | ||